Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript
Call Start: 16:30 January 1, 0000 4:57 PM ET Quantum BioPharma Ltd. (NASDAQ:QNTM ) Business Update Conference Call May 6, 2025, 04:30 PM ET Company Participants Zeeshan Saeed - Founder, Chief Executive Officer, President and Executive Co-Chair Jason Sawyer - Head of Finance and M&A Conference Call Participants Operator Greetings, and welcome to the Quantum BioPharma Business Update Conference Call.» Mehr auf seekingalpha.com
Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
To assist enquiries a copy of the amended complaint can be viewed by clicking the following link: Quantum Amended Court Claim» Mehr auf globenewswire.com
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), today announced it will host a Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m.» Mehr auf globenewswire.com
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 18,77 Mio€ |
Anzahl Aktien | 2,30 Mio |
52 Wochen-Hoch/Tief | 22,80€ - 2,43€ |
Dividenden | Nein |
Beta | 0,91 |
KGV (PE Ratio) | - |
KGWV (PEG Ratio) | - |
KBV (PB Ratio) | - |
KUV (PS Ratio) | - |
Unternehmensprofil
Name | Quantum BioPharma Aktie |
CEO | Zeeshan Saeed |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
München | 0K91.MU |
Düsseldorf | 0K91.DU |
Frankfurt | 0K91.F |
Assets entdecken
Shareholder von Quantum BioPharma Aktie investieren auch in folgende Assets